Drug Information

Drug General Information
Drug ID
D01NWS
Former ID
DNC013515
Drug Name
3-(biphenyl-4-yl)-1-(oxazol-2-yl)propan-1-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529284]
Structure
Download
2D MOL

3D MOL
Formula
C18H15NO2
Canonical SMILES
C1=CC=C(C=C1)C2=CC=C(C=C2)CCC(=O)C3=NC=CO3
InChI
1S/C18H15NO2/c20-17(18-19-12-13-21-18)11-8-14-6-9-16(10-7-14)15-4-2-1-3-5-15/h1-7,9-10,12-13H,8,11H2
InChIKey
RKXYRLSZCAAEPX-UHFFFAOYSA-N
PubChem Compound ID
24801394
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529284]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529284J Med Chem. 2008 Feb 28;51(4):937-47. Epub 2008 Feb 5.Optimization of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.
Ref 529284J Med Chem. 2008 Feb 28;51(4):937-47. Epub 2008 Feb 5.Optimization of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.